Deepika Pakianathan, Director at Karyopharm Therapeutics Inc. (KPTI), sold 1,628,177 shares at $0.96 ($1.6M) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Open-market sale of $1.6M KPTI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 4,526 | $4K | 0.3% |
| 2 | $0.96 | 463,518 | $445K | 28.5% |
| 3 | $0.96 | 463,518 | $445K | 28.5% |
| 4 | $0.98 | 1,145 | $1K | 0.1% |
| 5 | $0.98 | 117,307 | $115K | 7.4% |
| 6 | $0.98 | 117,307 |
| $115K |
| 7.4% |
| 7 | $0.95 | 2,240 | $2K | 0.1% |
| 8 | $0.95 | 229,308 | $218K | 13.9% |
| 9 | $0.95 | 229,308 | $218K | 13.9% |
| Total | $0.96 avg | 1,628,177 | $1.6M | 100% |
| Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |
| KPTI | BUY | 2015-01-14 | $1.5M | — | Filing → |